Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease
NCT ID: NCT04391712
Last Updated: 2020-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
10 participants
INTERVENTIONAL
2020-04-30
2020-07-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Respiratory Muscle Training in People Who Have Had COVID-19 Disease
NCT04734561
Photobiomodulation Therapy Versus Integrated Myofascial Release Therapy Techniques In Patients With COVID-19 With Follow-Up Telerehabilitation
NCT06795841
Influence of Power and Wavelength on Photobiomodulation Therapy for Muscle Performance in Healthy Subjects
NCT04809415
Effects of Respiratory Muscle Training in Individuals With Long-term Post-COVID-19 Symptoms
NCT05597774
Local and Systemic Effects of Photobiomodulation Therapy on Muscle Performance and Recovery Post-exercise.
NCT03695458
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
Participants will receive MLS laser treatment along with regular inpatient medical care.
MLS Laser
Treatments will be delivered to the participants days 1-4, in a prone position using a 10 by 25 cm laser field across each lung with 7j/cm2 at 1500 Hz.
Control Group
Participants will receive regular inpatient medical care.
Regular Inpatient Medical Care
Regular inpatient medical care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MLS Laser
Treatments will be delivered to the participants days 1-4, in a prone position using a 10 by 25 cm laser field across each lung with 7j/cm2 at 1500 Hz.
Regular Inpatient Medical Care
Regular inpatient medical care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pulmonary compromise requiring oxygen support of approximately 2-6 liters
* Able to self prone, or support in self-sitting position
Exclusion Criteria
* Patients with autoimmune disorders or inflammatory conditions not related to COVID-19
* Pregnant women
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lowell General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Scott Sigman, MD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Scott Sigman, MD
Role: PRINCIPAL_INVESTIGATOR
Lowell General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lowell General Hospital
Lowell, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020.01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.